BrightSpring Health Services, Inc. (BTSG)
(Real Time Quote from BATS)
$12.04 USD
+0.08 (0.67%)
Updated Jul 23, 2024 03:26 PM ET
2-Buy of 5 2
A Value B Growth D Momentum B VGM
Price, Consensus and EPS Surprise
BTSG 12.04 +0.08(0.67%)
Will BTSG be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for BTSG based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BTSG
Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?
Wall Street Analysts Think BrightSpring Health Services, Inc. (BTSG) Could Surge 38.15%: Read This Before Placing a Bet
BTSG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BTSG
IPO Roundup: Lineage, OneStream Software, and more
Wall Street Breakfast: The Week Ahead
BrightSpring Health Services Earns Multiple Accreditations Across the Country for Quality Care
BrightSpring Health Services, Inc. to Announce Second Quarter 2024 Financial Results on August 2, 2024
BrightSpring Health’s Strategic Acquisitions and Organic Growth Garner a Buy Rating